Enhanced CD33 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Enhanced CD33 CAR T cells, covering 2024-06-21 to 2024-06-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]